The relationship between regulatory T cells and radiation therapy

Area of Science:

• Oncology
• Immunology
• Radiotherapy

Background:

• Radiation therapy (RT) is a cornerstone cancer treatment, utilized by approximately 70% of patients in China.
• The immune-modulating effects of RT are increasingly recognized, with documented synergy between radiation and immunotherapy.
• Regulatory T cells (Tregs) are crucial immunosuppressive immune cells implicated in cancer progression, treatment resistance, and patient prognosis.

Purpose of the Study:

• To review the intricate interactions between radiation therapy and immune molecules, focusing on regulatory T cells (Tregs).
• To provide novel insights into combining RT with immunotherapy by understanding Treg-mediated immunosuppression in the tumor microenvironment.

Main Methods:

• Literature review of studies investigating the interplay between radiation therapy and the immune system.
• Analysis of the immunological characteristics of regulatory T cells (Tregs) in the context of cancer.
• Examination of Treg-mediated mechanisms including cell-cell contact, cytokine signaling, and metabolic pathways.

Main Results:

• Radiation therapy can modulate the tumor microenvironment, influencing Treg populations and function.
• Tregs play a significant role in tumor pathogenesis, development, and response to treatment.
• Understanding Treg dynamics is key to optimizing combination strategies involving RT and immunotherapy.

Conclusions:

• The interaction between RT and Tregs presents a critical target for enhancing cancer immunotherapy.
• Leveraging the immune-modulating effects of RT, particularly on Tregs, offers promising avenues for novel therapeutic combinations.
• Further research into Treg-specific targeting in conjunction with RT could significantly improve patient outcomes in oncology.